X4 Pharmaceuticals, Inc (XFOR) — Revenue
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $35.11M | +1273.2% |
| 2024 | $2.56M | — |
| 2023 | $0 | — |
| 2022 | $0 | — |
| 2021 | $0 | -100.0% |
| 2020 | $3.00M | — |
| 2019 | $0 | — |
| 2018 | $0 | — |
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $35.11M | +1273.2% |
| 2024 | $2.56M | — |
| 2023 | $0 | — |
| 2022 | $0 | — |
| 2021 | $0 | -100.0% |
| 2020 | $3.00M | — |
| 2019 | $0 | — |
| 2018 | $0 | — |